Skip to main content

LoPriore Vincent S

In the past year, 2 open-market purchase filings worth $750.0K and no sales.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$750.0K
2 filings
Sold
–
0 filings
Net
+$750.0K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists LoPriore Vincent S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

HEPA Hepion Pharmaceuticals, Inc.

Executive Chairman4 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 14, 2026 (view filing)6:30 AM ETSep 311 daysLateLoPriore Vincent SExecutive ChairmanPPurchase+12.5M$0.00$0–22.5M afterDerivative
Aug 12, 2026 (view filing)9:34 PM ETAug 39 daysLateLoPriore Vincent SExecutive ChairmanPPurchase+10.0M$0.05+$500.0K+160.0%16.3M after2 lots
Aug 12, 2026 (view filing)9:34 PM ETAug 39 daysLateLoPriore Vincent SExecutive ChairmanPPurchase+10.0M$0.00$0–10.0M afterDerivative2 lots
Apr 27, 2026 (view filing)6:24 AM ETApr 216 daysLateLoPriore Vincent SExecutive ChairmanPPurchaseCommon Stock, par value $0.0001 per share+6.25M$0.04+$250.0KNew position6.25M after2 lots